Survival after recurrence of osteosarcoma: A 20-year experience at a single institution

Pediatric Blood and Cancer

Volumn 47, Issue 3, 2006, Pages 255-259

  Crompton, Brian D ^a   Goldsby, Robert E ^a   Weinberg, Vivian K ^b   Feren, Robert ^c   O'Donnell, Richard J ^d   Ablin, Arthur R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SANTA BARBARA COTTAGE HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemotherapy; Metastasis; Osteosarcoma; Relapse; Surgery

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGISTRY; CANCER RELAPSE; CANCER SURVIVAL; CHILD; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; OSTEOSARCOMA; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; QUESTIONNAIRES; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33746586965     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20580     Document Type: Article

References (23)

1. Bacci G, Picci P, Ferrari S, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 1993;72:3227-3238.
2. Eilber F, Giuliano A, Eckardt J, et al. Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial. J Clin Oncol 1987;5:21-26.
3. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the cooperative German-Austrian-Swiss osteosarcoma study group's protocol coss-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998;9:893-899.
4. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600-1606.
5. Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: The memorial sloan-kettering experience. J Clin Oncol 1992;10:5-15.
6. Pratt CB, Champion JE, Fleming ID, et al. Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive prospective protocol studies. Cancer 1990;65:439-445.
7. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the children's cancer group. J Clin Oncol 1997;15:76-84.
8. Saeter G, Alvegard TA, Elomaa I, et al. Treatment of osteosarcoma of the extremities with the t-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian sarcoma group study. J Clin Oncol 1991;9:1766-1775.
9. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (coss-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988;6:329-337.
10. Tabone MD, Kalifa C, Rodary C, et al. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol 1994;12:2614-2620.
11. Duffaud F, Digue L, Mercier C, et al. Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy. Eur J Cancer 2003;39:2050-2057.
12. Fagioli F, Aglietta M, Tienghi A, et al. High-dose chemotherapy in the treatment of relapsed osteosarcoma: An Italian sarcoma group study. J Clin Oncol 2002;20:2150-2156.
13. Ferrari S, Briccoli A, Mercuri M, et al. Postrelapse survival in osteosarcoma of the extremities: Prognostic factors for long-term survival. J Clin Oncol 2003;21:710-715.
14. Hawkins DS, Arndt CA. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 2003;98:2447-2456.
15. Saeter G, Hoie J, Stenwig AE, et al. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival. Cancer 1995;75:1084-1093.
16. Kempf-Bielack B, Bielack SS, Jurgens H, et al. Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the cooperative osteosarcoma study group (coss). J Clin Oncol 2005;23:559-568.
17. Strauss SJ, McTiernan A, Whelan JS. Late relapse of osteosarcoma: Implications for follow-up and screening. Pediatr Blood Cancer 2004;43:692-697.
18. Bacci G, Avella M, Picci P, et al. Metastatic patterns in osteosarcoma. Tumori 1988;74:421-427.
19. Bacci G, Ruggieri P, Picci P, et al. Changing pattern of relapse in osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy. J Chemother 1995;7:230-239.
20. Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin North Am 1997;44:973-989.
21. Kandioler D, Kromer E, Tuchler H, et al. Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 1998;65:909-912.
22. McCarville MB, Kaste SC, Cain AM, et al. Prognostic factors and imaging patterns of recurrent pulmonary nodules after thoracotomy in children with osteosarcoma. Cancer 2001;91:1170-1176.
23. Ochi K, Daigo Y, Katagiri T, et al. Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles. Int J Oncol 2004;24:647-655.